nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—amyotrophic lateral sclerosis—Parkinson's disease	0.939	1	CtDrD
Riluzole—SLC7A11—forelimb zeugopod—Parkinson's disease	0.0119	0.453	CbGeAlD
Riluzole—SLC7A11—tongue—Parkinson's disease	0.00319	0.122	CbGeAlD
Riluzole—SLC7A11—forebrain—Parkinson's disease	0.00135	0.0516	CbGeAlD
Riluzole—SLC7A11—midbrain—Parkinson's disease	0.000893	0.0341	CbGeAlD
Riluzole—SLC7A11—spinal cord—Parkinson's disease	0.000871	0.0333	CbGeAlD
Riluzole—SLC7A11—head—Parkinson's disease	0.000774	0.0296	CbGeAlD
Riluzole—SLC7A11—nervous system—Parkinson's disease	0.000734	0.028	CbGeAlD
Riluzole—SLC7A11—central nervous system—Parkinson's disease	0.000707	0.027	CbGeAlD
Riluzole—SLC7A11—cerebellum—Parkinson's disease	0.000691	0.0264	CbGeAlD
Riluzole—SCN5A—cardiovascular system—Parkinson's disease	0.000688	0.0263	CbGeAlD
Riluzole—SLC7A11—brain—Parkinson's disease	0.000561	0.0214	CbGeAlD
Riluzole—SCN5A—head—Parkinson's disease	0.000466	0.0178	CbGeAlD
Riluzole—SCN5A—nervous system—Parkinson's disease	0.000442	0.0169	CbGeAlD
Riluzole—SCN5A—central nervous system—Parkinson's disease	0.000425	0.0162	CbGeAlD
Riluzole—SCN5A—brain—Parkinson's disease	0.000338	0.0129	CbGeAlD
Riluzole—ABCG2—medulla oblongata—Parkinson's disease	0.000322	0.0123	CbGeAlD
Riluzole—ABCG2—midbrain—Parkinson's disease	0.000294	0.0112	CbGeAlD
Riluzole—ABCG2—spinal cord—Parkinson's disease	0.000287	0.011	CbGeAlD
Riluzole—CYP1A1—head—Parkinson's disease	0.000242	0.00924	CbGeAlD
Riluzole—CYP1A1—nervous system—Parkinson's disease	0.000229	0.00876	CbGeAlD
Riluzole—ABCG2—cerebellum—Parkinson's disease	0.000227	0.00869	CbGeAlD
Riluzole—CYP1A1—central nervous system—Parkinson's disease	0.000221	0.00844	CbGeAlD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000212	0.00602	CbGpPWpGaD
Riluzole—CYP1A1—Oxidative Stress—NQO1—Parkinson's disease	0.000212	0.006	CbGpPWpGaD
Riluzole—CYP1A2—Xenobiotics—CYP2D6—Parkinson's disease	0.000206	0.00585	CbGpPWpGaD
Riluzole—SCN5A—L1CAM interactions—DLG4—Parkinson's disease	0.000206	0.00585	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—NRTN—Parkinson's disease	0.000203	0.00577	CbGpPWpGaD
Riluzole—CYP1A2—Estrogen metabolism—NQO1—Parkinson's disease	0.000203	0.00576	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—GSTP1—Parkinson's disease	0.000203	0.00576	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—HMOX1—Parkinson's disease	0.0002	0.00568	CbGpPWpGaD
Riluzole—CYP1A2—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000198	0.00563	CbGpPWpGaD
Riluzole—ABCG2—Fluoropyrimidine Activity—MTHFR—Parkinson's disease	0.000196	0.00557	CbGpPWpGaD
Riluzole—ABCG2—Iron uptake and transport—HMOX1—Parkinson's disease	0.000193	0.00547	CbGpPWpGaD
Riluzole—CYP1A2—Xenobiotics—CYP2E1—Parkinson's disease	0.000189	0.00535	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—GSTM1—Parkinson's disease	0.000186	0.00529	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—HGF—Parkinson's disease	0.000186	0.00529	CbGpPWpGaD
Riluzole—ABCG2—brain—Parkinson's disease	0.000185	0.00706	CbGeAlD
Riluzole—CYP1A2—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000181	0.00515	CbGpPWpGaD
Riluzole—CYP1A1—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000181	0.00513	CbGpPWpGaD
Riluzole—CYP1A1—Oxidative Stress—SOD1—Parkinson's disease	0.000181	0.00513	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—DLG1—Parkinson's disease	0.000178	0.00504	CbGpPWpGaD
Riluzole—CYP1A1—Oxidative Stress—MAOA—Parkinson's disease	0.000176	0.00499	CbGpPWpGaD
Riluzole—CYP1A1—brain—Parkinson's disease	0.000175	0.0067	CbGeAlD
Riluzole—SCN5A—Cardiac Progenitor Differentiation—INS—Parkinson's disease	0.000175	0.00496	CbGpPWpGaD
Riluzole—CYP1A1—Oxidative Stress—HMOX1—Parkinson's disease	0.000174	0.00494	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—Parkinson's disease	0.000172	0.00488	CbGpPWpGaD
Riluzole—CYP1A2—Estrogen metabolism—COMT—Parkinson's disease	0.00017	0.00483	CbGpPWpGaD
Riluzole—CYP1A2—Tryptophan metabolism—DDC—Parkinson's disease	0.000169	0.00481	CbGpPWpGaD
Riluzole—CYP1A1—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000169	0.00478	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—Parkinson's disease	0.000167	0.00473	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—MAG—Parkinson's disease	0.000164	0.00466	CbGpPWpGaD
Riluzole—CYP1A1—Oxidative Stress—SOD2—Parkinson's disease	0.000163	0.00462	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000163	0.00461	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000157	0.00444	CbGpPWpGaD
Riluzole—CYP1A2—Estrogen metabolism—GSTM1—Parkinson's disease	0.000156	0.00441	CbGpPWpGaD
Riluzole—CYP1A1—Oxidative Stress—GPX1—Parkinson's disease	0.000155	0.00441	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000154	0.00437	CbGpPWpGaD
Riluzole—CYP1A2—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.000153	0.00435	CbGpPWpGaD
Riluzole—CYP1A1—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000152	0.00431	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000151	0.00429	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00015	0.00426	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.00015	0.00426	CbGpPWpGaD
Riluzole—CYP1A1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000147	0.00416	CbGpPWpGaD
Riluzole—CYP1A2—Tryptophan metabolism—MAOB—Parkinson's disease	0.000143	0.00405	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—GDNF—Parkinson's disease	0.000139	0.00395	CbGpPWpGaD
Riluzole—CYP1A1—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000137	0.00389	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.000137	0.00388	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000135	0.00382	CbGpPWpGaD
Riluzole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000134	0.00381	CbGpPWpGaD
Riluzole—CYP1A1—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000133	0.00376	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—ABCB1—Parkinson's disease	0.000131	0.00373	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.000129	0.00366	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—DLG1—Parkinson's disease	0.000127	0.0036	CbGpPWpGaD
Riluzole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000123	0.0035	CbGpPWpGaD
Riluzole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000123	0.00349	CbGpPWpGaD
Riluzole—CYP1A1—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000121	0.00344	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000117	0.00332	CbGpPWpGaD
Riluzole—CYP1A2—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000115	0.00327	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000114	0.00323	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00011	0.00311	CbGpPWpGaD
Riluzole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000109	0.00309	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000108	0.00306	CbGpPWpGaD
Riluzole—CYP1A2—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000107	0.00305	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—FGB—Parkinson's disease	0.000104	0.00294	CbGpPWpGaD
Riluzole—CYP1A1—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000103	0.00293	CbGpPWpGaD
Riluzole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	9.96e-05	0.00283	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—GDNF—Parkinson's disease	9.92e-05	0.00282	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—NGF—Parkinson's disease	9.74e-05	0.00276	CbGpPWpGaD
Riluzole—CYP1A2—Tryptophan metabolism—CYP2E1—Parkinson's disease	9.69e-05	0.00275	CbGpPWpGaD
Riluzole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	9.63e-05	0.00273	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	9.58e-05	0.00272	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	9.58e-05	0.00272	CbGpPWpGaD
Riluzole—CYP1A2—Phase II conjugation—GSTA4—Parkinson's disease	9.52e-05	0.0027	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	9.34e-05	0.00265	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	9.27e-05	0.00263	CbGpPWpGaD
Riluzole—CYP1A2—Melatonin metabolism and effects—APOE—Parkinson's disease	8.74e-05	0.00248	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—GSTA4—Parkinson's disease	8.73e-05	0.00248	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—GSTA4—Parkinson's disease	8.61e-05	0.00244	CbGpPWpGaD
Riluzole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	8.57e-05	0.00243	CbGpPWpGaD
Riluzole—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	8.45e-05	0.0024	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—HSPA8—Parkinson's disease	8.31e-05	0.00236	CbGpPWpGaD
Riluzole—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	8.2e-05	0.00233	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—CTGF—Parkinson's disease	8.12e-05	0.0023	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	7.99e-05	0.00227	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	7.99e-05	0.00227	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—Parkinson's disease	7.95e-05	0.00226	CbGpPWpGaD
Riluzole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	7.83e-05	0.00222	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—DLG4—Parkinson's disease	7.79e-05	0.00221	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—MAOB—Parkinson's disease	7.78e-05	0.00221	CbGpPWpGaD
Riluzole—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	7.73e-05	0.00219	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—SOD1—Parkinson's disease	7.69e-05	0.00218	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.68e-05	0.00218	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—GRIN2B—Parkinson's disease	7.62e-05	0.00216	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.37e-05	0.00209	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—ABL1—Parkinson's disease	7.34e-05	0.00208	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—IGF2—Parkinson's disease	7.3e-05	0.00207	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	6.94e-05	0.00197	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—HGF—Parkinson's disease	6.9e-05	0.00196	CbGpPWpGaD
Riluzole—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	6.58e-05	0.00187	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.41e-05	0.00182	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	6.35e-05	0.0018	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—ABL1—Parkinson's disease	6.21e-05	0.00176	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.15e-05	0.00175	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	6.04e-05	0.00171	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—HSPA8—Parkinson's disease	5.93e-05	0.00168	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—CYP2D6—Parkinson's disease	5.78e-05	0.00164	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—CYP2D6—Parkinson's disease	5.71e-05	0.00162	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	5.57e-05	0.00158	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—DLG4—Parkinson's disease	5.56e-05	0.00158	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	5.5e-05	0.00156	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	5.49e-05	0.00156	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	5.48e-05	0.00156	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—Parkinson's disease	5.48e-05	0.00155	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—GRIN2B—Parkinson's disease	5.44e-05	0.00154	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—CYP2E1—Parkinson's disease	5.29e-05	0.0015	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	5.23e-05	0.00148	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—CYP2E1—Parkinson's disease	5.22e-05	0.00148	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	4.96e-05	0.00141	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	4.84e-05	0.00137	CbGpPWpGaD
Riluzole—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	4.78e-05	0.00136	CbGpPWpGaD
Riluzole—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	4.76e-05	0.00135	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—ABL1—Parkinson's disease	4.43e-05	0.00126	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—COMT—Parkinson's disease	4.38e-05	0.00124	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	4.38e-05	0.00124	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	4.38e-05	0.00124	CbGpPWpGaD
Riluzole—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	4.37e-05	0.00124	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—GSTP1—Parkinson's disease	4.36e-05	0.00124	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—MAOA—Parkinson's disease	4.35e-05	0.00124	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—COMT—Parkinson's disease	4.32e-05	0.00123	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—GSTP1—Parkinson's disease	4.3e-05	0.00122	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	4.24e-05	0.0012	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ND3—Parkinson's disease	4.2e-05	0.00119	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—MCCC1—Parkinson's disease	4.2e-05	0.00119	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—GSTM1—Parkinson's disease	4.01e-05	0.00114	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	3.99e-05	0.00113	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—GSTM1—Parkinson's disease	3.95e-05	0.00112	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—OMD—Parkinson's disease	3.95e-05	0.00112	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—TALDO1—Parkinson's disease	3.95e-05	0.00112	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—CP—Parkinson's disease	3.9e-05	0.00111	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	3.85e-05	0.00109	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NDUFB11—Parkinson's disease	3.74e-05	0.00106	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	3.69e-05	0.00105	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	3.64e-05	0.00103	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GCH1—Parkinson's disease	3.57e-05	0.00101	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	3.37e-05	0.000957	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.33e-05	0.000944	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.22e-05	0.000913	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GBA—Parkinson's disease	3.18e-05	0.000903	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—FBP1—Parkinson's disease	3.18e-05	0.000903	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—DBH—Parkinson's disease	3.18e-05	0.000903	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	3.08e-05	0.000875	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3.02e-05	0.000857	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—INS—Parkinson's disease	2.93e-05	0.000831	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ND3—Parkinson's disease	2.84e-05	0.000807	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MCCC1—Parkinson's disease	2.84e-05	0.000807	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—COMT—Parkinson's disease	2.8e-05	0.000793	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	2.79e-05	0.000793	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	2.79e-05	0.000793	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	2.78e-05	0.00079	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.78e-05	0.000789	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	2.78e-05	0.000788	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	2.76e-05	0.000782	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	2.74e-05	0.000779	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TALDO1—Parkinson's disease	2.67e-05	0.000759	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—OMD—Parkinson's disease	2.67e-05	0.000759	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.67e-05	0.000758	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	2.56e-05	0.000726	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NDUFB11—Parkinson's disease	2.53e-05	0.000719	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	2.52e-05	0.000716	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GCH1—Parkinson's disease	2.42e-05	0.000686	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—DDC—Parkinson's disease	2.34e-05	0.000663	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.32e-05	0.000659	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.23e-05	0.000632	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTA4—Parkinson's disease	2.21e-05	0.000626	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.18e-05	0.000619	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GBA—Parkinson's disease	2.15e-05	0.000611	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—FBP1—Parkinson's disease	2.15e-05	0.000611	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—DBH—Parkinson's disease	2.15e-05	0.000611	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PLA2G6—Parkinson's disease	1.99e-05	0.000564	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—MAOB—Parkinson's disease	1.97e-05	0.000558	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	1.93e-05	0.000546	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MCCC1—Parkinson's disease	1.81e-05	0.000514	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ND3—Parkinson's disease	1.81e-05	0.000514	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—IL6—Parkinson's disease	1.79e-05	0.000509	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—OMD—Parkinson's disease	1.7e-05	0.000484	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TALDO1—Parkinson's disease	1.7e-05	0.000484	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	1.62e-05	0.000459	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TNF—Parkinson's disease	1.59e-05	0.00045	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—DDC—Parkinson's disease	1.58e-05	0.000449	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GCH1—Parkinson's disease	1.54e-05	0.000437	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTA4—Parkinson's disease	1.49e-05	0.000424	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.47e-05	0.000418	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP2D6—Parkinson's disease	1.46e-05	0.000415	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CTGF—Parkinson's disease	1.43e-05	0.000407	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.39e-05	0.000395	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—DBH—Parkinson's disease	1.37e-05	0.00039	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—FBP1—Parkinson's disease	1.37e-05	0.00039	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GBA—Parkinson's disease	1.37e-05	0.00039	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PLA2G6—Parkinson's disease	1.34e-05	0.000382	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP2E1—Parkinson's disease	1.34e-05	0.000379	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MAOB—Parkinson's disease	1.33e-05	0.000378	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NQO1—Parkinson's disease	1.32e-05	0.000375	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—TH—Parkinson's disease	1.3e-05	0.00037	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—IL6—Parkinson's disease	1.28e-05	0.000363	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.27e-05	0.00036	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYCS—Parkinson's disease	1.25e-05	0.000355	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—COMT—Parkinson's disease	1.11e-05	0.000314	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTP1—Parkinson's disease	1.1e-05	0.000313	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—MAOA—Parkinson's disease	1.1e-05	0.000312	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HMOX1—Parkinson's disease	1.09e-05	0.000309	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ABCB1—Parkinson's disease	1.04e-05	0.000296	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTM1—Parkinson's disease	1.01e-05	0.000287	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—DDC—Parkinson's disease	1.01e-05	0.000286	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	9.89e-06	0.000281	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CTGF—Parkinson's disease	9.71e-06	0.000276	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GPX1—Parkinson's disease	9.7e-06	0.000275	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA4—Parkinson's disease	9.52e-06	0.00027	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	9.4e-06	0.000267	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	9.05e-06	0.000257	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—MTHFR—Parkinson's disease	8.95e-06	0.000254	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NQO1—Parkinson's disease	8.95e-06	0.000254	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TH—Parkinson's disease	8.82e-06	0.00025	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	8.57e-06	0.000243	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MAOB—Parkinson's disease	8.49e-06	0.000241	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYCS—Parkinson's disease	8.47e-06	0.00024	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APOE—Parkinson's disease	8.33e-06	0.000237	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	8.08e-06	0.000229	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—COMT—Parkinson's disease	7.5e-06	0.000213	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTP1—Parkinson's disease	7.46e-06	0.000212	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MAOA—Parkinson's disease	7.44e-06	0.000211	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HMOX1—Parkinson's disease	7.36e-06	0.000209	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—INS—Parkinson's disease	7.12e-06	0.000202	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCB1—Parkinson's disease	7.06e-06	0.0002	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTM1—Parkinson's disease	6.86e-06	0.000195	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GPX1—Parkinson's disease	6.57e-06	0.000186	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	6.31e-06	0.000179	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CTGF—Parkinson's disease	6.19e-06	0.000176	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MTHFR—Parkinson's disease	6.06e-06	0.000172	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	5.77e-06	0.000164	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NQO1—Parkinson's disease	5.7e-06	0.000162	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APOE—Parkinson's disease	5.64e-06	0.00016	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TH—Parkinson's disease	5.62e-06	0.00016	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYCS—Parkinson's disease	5.4e-06	0.000153	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—INS—Parkinson's disease	4.82e-06	0.000137	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—COMT—Parkinson's disease	4.78e-06	0.000136	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTP1—Parkinson's disease	4.76e-06	0.000135	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MAOA—Parkinson's disease	4.75e-06	0.000135	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HMOX1—Parkinson's disease	4.69e-06	0.000133	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCB1—Parkinson's disease	4.5e-06	0.000128	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTM1—Parkinson's disease	4.37e-06	0.000124	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GPX1—Parkinson's disease	4.19e-06	0.000119	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MTHFR—Parkinson's disease	3.86e-06	0.00011	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APOE—Parkinson's disease	3.6e-06	0.000102	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—INS—Parkinson's disease	3.07e-06	8.72e-05	CbGpPWpGaD
